Hemodynamic effects of inotropic drugs in heart failure
Authors:
Open Access
- 1 November 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (47) , e18144
Abstract
Background: There is currently no consensus on the appropriate selection of inotropic therapy in ventricular dysfunction. The objective of the study was to detect the effects of different inotropes on the hemodynamics of patients who developed low cardiac output. Methods: PubMed, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched (all updated December 31, 2017). The inclusion criteria were as follows: low cardiac index (CI < 2.5 L/min/m2) or New York Heart Association class II–IV, and at least 1 group receiving an inotropic drug compared to another group receiving a different inotropic/placebo treatment. The exclusion criteria were studies published as an abstract only, crossover studies, and studies with a lack of data on the cardiac index. Results: A total of 1402 patients from 37 trials were included in the study. Inotropic drugs were shown to increase the cardiac index (0.32, 95%CI:0.25, 0.38), heart rate (7.68, 95%CI:6.36, 9.01), and mean arterial pressure (3.17, 95%CI:1.96, 4.38) than the placebo. Overall, the pooled estimates showed no difference in terms of cardiac index, heart rate, mean arterial pressure, systemic vascular resistance, and mean pulmonary arterial pressure among the groups receiving different inotropes. Conclusions: Our systematic review found that inotrope therapy is not associated with the amelioration of hemodynamics. An accurate evaluation of the benefits and risks, and selection of the correct inotropic agent is required in all clinical settings.Keywords
This publication has 83 references indexed in Scilit:
- Effectiveness of prophylactic levosimendan in high-risk valve surgery patients : cardiovascular topicsCardioVascular Journal of Africa, 2013
- ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012European Journal of Heart Failure, 2012
- Aliskiren, ALTITUDE, and the Implications for ATMOSPHEREEuropean Journal of Heart Failure, 2012
- Intravenous Levosimendan vs. Dobutamine in Acute Decompensated Heart Failure Patients on Beta-BlockersEuropean Journal of Heart Failure, 2010
- Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trialsEuropean Heart Journal, 2009
- The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass graftingCritical Care, 2007
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- The Effects of Two New Inotropic Agents on Microsomal Liver Function in Patients with Congestive Heart FailureThe American Journal of the Medical Sciences, 1986
- Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.Circulation, 1984